Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 4/20 | 0.44 |
| ▸ | TUBB | P07437 | 4/20 | 0.44 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.44 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.44 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.44 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.44 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.44 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.44 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.44 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.44 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.44 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.44 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.44 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.44 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL940398 | 0.78 | BRD9 (0.42) | PTGS2KMT2AMEN1NPC1RAB9A | |
| SCHEMBL941849 | 0.74 | CYP2C9 (0.53) | PTGS2KMT2AMEN1NPC1RAB9A | |
| SCHEMBL1912040 | 0.69 | CYP3A4 (0.48) | CYP2C9CYP1A2ALDH1A1 | |
| SCHEMBL17725702 | 0.69 | KMT2A (0.55) | PTGS2KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL27899616 | 0.67 | MEN1 (0.39) | PTGS2KMT2AMEN1NPC1RAB9A | |
| SCHEMBL1912000 | 0.66 | LRRK2 (0.45) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1911845 | 0.66 | CYP11B1 (0.59) | CYP2C9CYP1A2LMNA | |
| SCHEMBL22827475 | 0.65 | HTT (0.44) | KMT2AMEN1L3MBTL1ALDH1A1 | |
| SCHEMBL9042497 | 0.65 | P2RX7 (0.42) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL30958058 | 0.65 | ACHE (0.39) | TUBB1S1PR1DHFRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015403-A1 | PROCESS FOR PREPARING IODINATED AZOLES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| EP-1979333-A1 | PROCESS FOR PREPARING IODINATED AZOLES | Lanxess Deutschland GmbH (DE) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007085349-A1 | PROCESS FOR PREPARING IODINATED AZOLES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015403-A1 | PROCESS FOR PREPARING IODINATED AZOLES | AZI2, TPO, INSR | TUBB4A 452/4885TUBB 725/4885TUBA3C 563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.